#CancerTreatment #radiopharmaceuticals #radiolabeling

New IAEA Project to Advance Terbium-Based Radiopharmaceuticals for Improved Theranostics

Author(s): MedEdge MEA

Theranostic radiopharmaceuticals, which combine diagnosis and therapy within a single administration, are transforming the management of cancer and other diseases.  

The IAEA is inviting research organizations to participate in a new coordinated research project supporting the development and harmonization of production methods, radiolabeling strategies and quality control procedures for terbium radioisotopes, while strengthening technical capacity across participating institutions - Read More 

Related Articles

View All
New IAEA Project to Advance Terbium-Based Radiopharmaceuticals for Improved Theranostics MedEdge MEA

Theranostic radiopharmaceuticals, which combine diagnosis and therapy within a single administration, are transforming the management of cancer and other diseases.   T...

Read More
EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma MedEdge MEA

AbbVie recently announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for the treatment...

Read More
Menu
Categories
How does it work